(3aR,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aR,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(4aR,7aS)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;(4aS,7aR)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine
C117H178N24O3 — CID 157050014
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3aR,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aR,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(4aR,7aS)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;(4aS,7aR)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine
(3aR,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aR,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(4aR,7aS)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;(4aS,7aR)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine (PubChem CID 157050014) has the molecular formula C117H178N24O3 and a molecular weight of 1968.88 g/mol. Its IUPAC name is (3aR,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aR,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(4aR,7aS)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;(4aS,7aR)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine.
Molecular Properties
| Compound Name | (3aR,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aR,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(4aR,7aS)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;(4aS,7aR)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine |
|---|---|
| PubChem CID | 157050014 |
| Molecular Formula | C117H178N24O3 |
| Molecular Weight | 1968.88 g/mol |
| Exact Mass | 1967.45 |
| IUPAC Name | (3aR,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aR)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aR,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(3aS,6aS)-5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;(4aR,7aS)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;(4aS,7aR)-4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine;5-methyl-1-(6-propan-2-yl-2-pyridinyl)-2,3,3a,4,6,6a-hexahydropyrrolo[2,3-c]pyrrole;4-(6-propan-2-yl-3-pyridinyl)-3,4a,5,6,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazine |
| SMILES | CC(C)c1ccc(N2CCOC3CNCC32)cn1.CC(C)c1ccc(N2CCO[C@@H]3CNC[C@@H]32)cn1.CC(C)c1ccc(N2CCO[C@H]3CNC[C@H]32)cn1.CC(C)c1cccc(N2CCC3CN(C)CC32)n1.CC(C)c1cccc(N2CC[C@@H]3CN(C)C[C@@H]32)n1.CC(C)c1cccc(N2CC[C@@H]3CN(C)C[C@H]32)n1.CC(C)c1cccc(N2CC[C@H]3CN(C)C[C@@H]32)n1.CC(C)c1cccc(N2CC[C@H]3CN(C)C[C@H]32)n1 |
| InChI | InChI=1S/5C15H23N3.3C14H21N3O/c5*1-11(2)13-5-4-6-15(16-13)18-8-7-12-9-17(3)10-14(12)18;3*1-10(2)12-4-3-11(7-16-12)17-5-6-18-14-9-15-8-13(14)17/h5*4-6,11-12,14H,7-10H2,1-3H3;3*3-4,7,10,13-15H,5-6,8-9H2,1-2H3/t2*12-,14+;2*12-,14-;;2*13-,14+;/m1010.10./s1 |
| InChIKey | AABWSKWGJDIWCO-UUKHPXIASA-N |
| XLogP | 15.87 |
| TPSA | 209.02 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 27 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 144 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1968.88 |
| LogP ≤ 5 | 15.87 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 27 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157050014 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.